CR1001b : Multiple cervix cancer with cervix tissue array, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replaced by CR1001b
|
Microarray Panel | Multiple cervix carcinoma with cervix tissue microarray, containing 15 cases of adenocarcinoma, 5 adenosquamous carcinoma, 20 squamous cell carcinoma, 4 each cases of cancer adjacent tissue and adjacent normal tissue, 2 cervix tissue, duplicated cores per case | |
Cores | 100 | |
Cases | 50 | |
Row number | 10 | |
Column number | 10 | |
Core Diameter (mm) | 1 | |
Thickness (µm) | 5 | |
Tissue Array Type | FFPE | |
Species | Human | |
Applications | Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. | |
Notes | 1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours. In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Legend: | Cer - Cervix
|
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Pos. | No. | Age | Sex | Organ/Anatomic Site | Pathology diagnosis | TNM | Grade | Stage | Type | Image |
---|
1 | 42 | F | Cervix | Adenocarcinoma | T1bN0M0 | 1 | IB | Malignant | ||
2 | 42 | F | Cervix | Adenocarcinoma | T1bN0M0 | 1 | IB | Malignant | ||
3 | 75 | F | Cervix | Adenocarcinoma | T1N0M0 | 1 | I | Malignant | ||
4 | 75 | F | Cervix | Adenocarcinoma | T1N0M0 | 1 | I | Malignant | ||
5 | 52 | F | Cervix | Adenocarcinoma | T1b2N0M0 | 1--2 | IB2 | Malignant | ||
6 | 52 | F | Cervix | Adenocarcinoma | T1b2N0M0 | 1--2 | IB2 | Malignant | ||
7 | 48 | F | Cervix | Adenocarcinoma | T1N0M0 | 1--2 | I | Malignant | ||
8 | 48 | F | Cervix | Adenocarcinoma | T1N0M0 | 1--2 | I | Malignant | ||
9 | 43 | F | Cervix | Adenocarcinoma | T1bN0M0 | 2 | IB | Malignant | ||
10 | 43 | F | Cervix | Adenocarcinoma | T1bN0M0 | 2 | IB | Malignant | ||
11 | 51 | F | Cervix | Adenocarcinoma | T1aN0M0 | 2 | IA | Malignant | ||
12 | 51 | F | Cervix | Adenocarcinoma | T1aN0M0 | 2 | IA | Malignant | ||
13 | 41 | F | Cervix | Mucinous adenocarcinoma | T1bN0M0 | 2 | IB | Malignant | ||
14 | 41 | F | Cervix | Mucinous adenocarcinoma | T1bN0M0 | 2 | IB | Malignant | ||
15 | 32 | F | Cervix | Adenocarcinoma | T1aN0M0 | 2 | IA | Malignant | ||
16 | 32 | F | Cervix | Adenocarcinoma | T1aN0M0 | 2 | IA | Malignant | ||
17 | 72 | F | Cervix | Adenocarcinoma | T2bN0M0 | 2 | IIB | Malignant | ||
18 | 72 | F | Cervix | Adenocarcinoma | T2bN0M0 | 2 | IIB | Malignant | ||
19 | 40 | F | Cervix | Adenocarcinoma | T1N0M0 | 2 | I | Malignant | ||
20 | 40 | F | Cervix | Adenocarcinoma | T1N0M0 | 2 | I | Malignant | ||
21 | 50 | F | Cervix | Adenocarcinoma | T1N1M0 | 2--3 | IIIB | Malignant | ||
22 | 50 | F | Cervix | Adenocarcinoma | T1N1M0 | 2--3 | IIIB | Malignant | ||
23 | 29 | F | Cervix | Adenocarcinoma | T2N0M0 | 2--3 | II | Malignant | ||
24 | 29 | F | Cervix | Adenocarcinoma | T2N0M0 | 2--3 | II | Malignant | ||
25 | 34 | F | Cervix | Adenocarcinoma | T2bN0M0 | 2--3 | IIB | Malignant | ||
26 | 34 | F | Cervix | Adenocarcinoma | T2bN0M0 | 2--3 | IIB | Malignant | ||
27 | 26 | F | Cervix | Endometrioid adenocarcinoma | T1N0M0 | 3 | I | Malignant | ||
28 | 26 | F | Cervix | Endometrioid adenocarcinoma | T1N0M0 | 3 | I | Malignant | ||
29 | 59 | F | Cervix | Adenocarcinoma | T1b1N0M0 | 3 | IB1 | Malignant | ||
30 | 59 | F | Cervix | Adenocarcinoma | T1b1N0M0 | 3 | IB1 | Malignant | ||
31 | 54 | F | Cervix | Adenosquamous carcinoma | T1bN0M0 | - | IB | Malignant | ||
32 | 54 | F | Cervix | Adenosquamous carcinoma | T1bN0M0 | - | IB | Malignant | ||
33 | 38 | F | Cervix | Adenosquamous carcinoma | T1bN0M0 | - | IB | Malignant | ||
34 | 38 | F | Cervix | Adenosquamous carcinoma | T1bN0M0 | - | IB | Malignant | ||
35 | 54 | F | Cervix | Adenosquamous carcinoma | T1bN0M0 | - | IB | Malignant | ||
36 | 54 | F | Cervix | Adenosquamous carcinoma | T1bN0M0 | - | IB | Malignant | ||
37 | 48 | F | Cervix | Adenosquamous carcinoma | T3N0M0 | - | III | Malignant | ||
38 | 48 | F | Cervix | Adenosquamous carcinoma | T3N0M0 | - | III | Malignant | ||
39 | 42 | F | Cervix | Adenosquamous carcinoma | T1aN0M0 | - | IA | Malignant | ||
40 | 42 | F | Cervix | Adenosquamous carcinoma | T1aN0M0 | - | IA | Malignant | ||
41 | 69 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 1 | IB | Malignant | ||
42 | 69 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 1 | IB | Malignant | ||
43 | 50 | F | Cervix | Squamous cell carcinoma | T2bN0M0 | 1 | IIB | Malignant | ||
44 | 50 | F | Cervix | Squamous cell carcinoma | T2bN0M0 | 1 | IIB | Malignant | ||
45 | 53 | F | Cervix | Squamous cell carcinoma | T1b2N0M0 | 1--2 | IB2 | Malignant | ||
46 | 53 | F | Cervix | Squamous cell carcinoma | T1b2N0M0 | 1--2 | IB2 | Malignant | ||
47 | 40 | F | Cervix | Squamous cell carcinoma | T1N0M0 | 1--2 | I | Malignant | ||
48 | 40 | F | Cervix | Squamous cell carcinoma | T1N0M0 | 1--2 | I | Malignant | ||
49 | 36 | F | Cervix | Squamous cell carcinoma | T1bN1M0 | 2 | IIIB | Malignant | ||
50 | 36 | F | Cervix | Squamous cell carcinoma | T1bN1M0 | 2 | IIIB | Malignant | ||
51 | 33 | F | Cervix | Squamous cell carcinoma | T2N0M0 | 2 | II | Malignant | ||
52 | 33 | F | Cervix | Squamous cell carcinoma | T2N0M0 | 2 | II | Malignant | ||
53 | 47 | F | Cervix | Squamous cell carcinoma | T2N0M0 | 2 | II | Malignant | ||
54 | 47 | F | Cervix | Squamous cell carcinoma | T2N0M0 | 2 | II | Malignant | ||
55 | 37 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 2 | IB | Malignant | ||
56 | 37 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 2 | IB | Malignant | ||
57 | 68 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 2 | IB | Malignant | ||
58 | 68 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 2 | IB | Malignant | ||
59 | 47 | F | Cervix | Squamous cell carcinoma | T1N0M0 | 2 | I | Malignant | ||
60 | 47 | F | Cervix | Squamous cell carcinoma | T1N0M0 | 2 | I | Malignant | ||
61 | 62 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 2 | IB | Malignant | ||
62 | 62 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 2 | IB | Malignant | ||
63 | 39 | F | Cervix | Squamous cell carcinoma | T4N0M0 | 2 | IVA | Malignant | ||
64 | 39 | F | Cervix | Squamous cell carcinoma | T4N0M0 | 2 | IVA | Malignant | ||
65 | 27 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 2 | IB | Malignant | ||
66 | 27 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 2 | IB | Malignant | ||
67 | 32 | F | Cervix | Squamous cell carcinoma | T1aN0M0 | 2 | IA | Malignant | ||
68 | 32 | F | Cervix | Squamous cell carcinoma | T1aN0M0 | 2 | IA | Malignant | ||
69 | 76 | F | Cervix | Squamous cell carcinoma | T2N0M0 | 2--3 | II | Malignant | ||
70 | 76 | F | Cervix | Squamous cell carcinoma | T2N0M0 | 2--3 | II | Malignant | ||
71 | 43 | F | Cervix | Squamous cell carcinoma | T1b1N0M0 | 2--3 | IB1 | Malignant | ||
72 | 43 | F | Cervix | Squamous cell carcinoma | T1b1N0M0 | 2--3 | IB1 | Malignant | ||
73 | 27 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 3 | IB | Malignant | ||
74 | 27 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 3 | IB | Malignant | ||
75 | 58 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 3 | IB | Malignant | ||
76 | 58 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 3 | IB | Malignant | ||
77 | 48 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 3 | IB | Malignant | ||
78 | 48 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 3 | IB | Malignant | ||
79 | 27 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 3 | IB | Malignant | ||
80 | 27 | F | Cervix | Squamous cell carcinoma | T1bN0M0 | 3 | IB | Malignant | ||
81 | 57 | F | Cervix | Cancer adjacent cervix tissue | - | - | - | AT | ||
82 | 57 | F | Cervix | Cancer adjacent cervix tissue | - | - | - | AT | ||
83 | 50 | F | Cervix | Cancer adjacent cervix tissue | - | - | - | AT | ||
84 | 50 | F | Cervix | Cancer adjacent cervix tissue | - | - | - | AT | ||
85 | 71 | F | Cervix | Cancer adjacent cervix tissue | - | - | - | AT | ||
86 | 71 | F | Cervix | Cancer adjacent cervix tissue | - | - | - | AT | ||
87 | 62 | F | Cervix | Cancer adjacent cervix tissue | - | - | - | AT | ||
88 | 62 | F | Cervix | Cancer adjacent cervix tissue | - | - | - | AT | ||
89 | 45 | F | Cervix | Adjacent normal cervix tissue | - | - | - | NAT | ||
90 | 45 | F | Cervix | Adjacent normal cervix tissue | - | - | - | NAT | ||
91 | 70 | F | Cervix | Adjacent normal cervix tissue | - | - | - | NAT | ||
92 | 70 | F | Cervix | Adjacent normal cervix tissue | - | - | - | NAT | ||
93 | 70 | F | Cervix | Adjacent normal cervix tissue | - | - | - | NAT | ||
94 | 70 | F | Cervix | Adjacent normal cervix tissue | - | - | - | NAT | ||
95 | 47 | F | Cervix | Adjacent normal cervix tissue | - | - | - | NAT | ||
96 | 47 | F | Cervix | Adjacent normal cervix tissue | - | - | - | NAT | ||
97 | 23 | F | Cervix | Cervix tissue | - | - | - | Normal | ||
98 | 23 | F | Cervix | Cervix tissue | - | - | - | Normal | ||
99 | 38 | F | Cervix | Cervix tissue | - | - | - | Normal | ||
100 | 38 | F | Cervix | Cervix tissue | - | - | - | Normal | ||
- | 0 | 42 | M | Adrenal gland | Pheochromocytoma (tissue marker) | - | Malignant |
Find overlapping cases with this tissue array:
- Product Code: CR1001b
- Availability: In Stock